Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties-Reference-Cited by-同舟云学术

Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties

Published:2018-02-01 Issue: Volume:9 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Ribeiro Filho Helder Veras,Bernardi Videira Natália,Bridi Aline Villanova,Tittanegro Thais Helena,Helena Batista Fernanda Aparecida,de Carvalho Pereira José Geraldo,de Oliveira Paulo Sérgio Lopes,Bajgelman Marcio Chaim,Le Maire Albane,Figueira Ana Carolina Migliorini

Funder

Fundaç ão de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenaç ão de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference60 articles.

1. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies;O’Neill;Obes Rev,2014

2. A comprehensive review on metabolic syndrome;Kaur;Cardiol Res Pract,2014

3. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training;Roberts;Compr Physiol,2013